Articles Vol. 67 No. Số CĐ12- Bệnh viện Ung bướu Nghệ An (2026) 25/08/2026

CASE REPORT: MULTIORGAN INJURY ASSOCIATED WITH KETAMINE ABUSE ON COMPUTED TOMOGRAPHY

Long Nguyen Tien1,2, Long Nguyen Tien1,2, Tuan Tran Duc1,2, Cuong Dang Manh1,2, My Ton Nu Tra1,2, Loan Tran Thi1,2, Thao Hoang Thi Phuong1,2, Quy Truong Quang1,2, Si Bui Tien1,2, Huy Huynh Tuan1,2, Huong Tran Thi Thu1,2
1 Vinmec Central Park International General Hospital
2 Bệnh viện Đa khoa Quốc tế Vinmec Central Park
DOI: 10.52163/yhc.v67iCD12.6285
339 Views
0 Downloads
Abstract

Background:Ketamine is a dissociative anesthetic that has been increasingly abused for recreational purposes. Ketamine-related urinary tract injury has been widely described; however, the presence of abnormalities involving multiple organs on computed tomography (CT) has not been fully reported in the literature.Case presentation:We report the case of a 34-year-old man who was admitted with prolonged fever, urinary frequency, and elevated liver enzymes.

Intervention and course:Contrast-enhanced CT demonstrated hepatomegaly, arterial-phase hepatic perfusion abnormalities, and multiple small scattered hypoattenuating lesions within the liver. Additional findings included intrahepatic bile duct wall thickening with fusiform dilation of the common bile duct, as well as a small-capacity urinary bladder with diffuse wall thickening. Other associated abnormalities included small bowel wall thickening and bilateral adrenal enlargement. Follow-up CT after treatment showed improvement in hepatic parenchymal lesions and reduced perfusion abnormalities.Conclusion:These findings suggest multiorgan involvement associated with chronic ketamine abuse and highlight the role of multiphasic CT in identifying associated abnormalities and supporting diagnostic orientation.

References
[1]
Schep LJ, Slaughter RJ, Watts M, Mackenzie E, Gee P. The clinical toxicology of ketamine. Clin Toxicol (Phila). 2023;61(6):415–428. doi:10.1080/15563650.2023.2212125. Google Scholar
[2]
Huang LK, Wang JH, Shen SH, Lin AT, Chang CY. Evaluation of the extent of ketamine-induced uropathy: the role of CT urography. Postgrad Med J. 2014;90(1062):185–190. doi:10.1136/postgradmedj-2013-131776. Google Scholar
[3]
Yu WL, Cho CC, Lung PF, Hung EH, Hui JW, Chau HH, Chan AW, Ahuja AT. Ketamine-related cholangiopathy: a retrospective study on clinical and imaging findings. Abdom Imaging. 2014;39(6):1241–1246. doi:10.1007/s00261-014-0173-2. Google Scholar
[4]
Peltoniemi MA, Hagelberg NM, Olkkola KT, Saari TI. Ketamine: a review of clinical pharmacokinetics and pharmacodynamics in anesthesia and pain therapy. Clin Pharmacokinet. 2016;55(9):1059–1077. doi:10.1007/s40262-016-0383-6. Google Scholar
[5]
Waheed HW, Ashraf MR, Sajjad T, Jehangir H, Baig I, Zulaid A, Nasir AR, Dad A. Hepatobiliary complications associated with ketamine use: clinical insights and future directions. Cureus. 2025;17(5):e84974. doi:10.7759/cureus.84974. Google Scholar
[6]
Nazir K, Ahmed W, Rafi S, Ahmad A, Khaleeq A. Ketamine-induced cholangiopathy with concomitant hemorrhagic cystitis: an emerging and underrecognized cause of cholestasis. Cureus. 2025;17(12):e99972. doi:10.7759/cureus.99972. Google Scholar